Media releases are provided as is by companies and have not been edited or checked for accuracy. Any queries should be directed to the company itself.
  • 6 December 2019 16:18

Stem Cell Therapy Market - Key Players, Analysis, Trends, Share, Segmentation, Industry Size 2030

According to the report The global stem cell therapy market was valued at over US$ 103 Mn in 2018 and is anticipated to grow at a CAGR of 9.8% from 2019 to 2030.

Market Industry Reports (MIR) has published a new report titled “Stem Cell Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030.” According to the report The global stem cell therapy market was valued at over US$ 103 Mn in 2018 and is anticipated to grow at a CAGR of 9.8% from 2019 to 2030.

Increasing burden of chronic diseases to boost the market growth

Increasing global burden of diseases such as diabetes, cancer, and others are projected to be the major factors leading to the market growth. According to the World Health Organization (WHO) in 2017, number of patients suffering from type I and type II diabetes was estimated to be over 422 million. Moreover, the disease is expected to be the seventh largest cause of death by 2030.

Get FREE Sample Copy with TOC to understand the structure of the complete report @ https://www.marketindustryreports.com/pdf/32

According to American Cancer Society, in 2017, there were over 1.6 million new cancer cases in the U.S. Hence, there exists a need for developing new treatment methods which have led to the rise in approvals of clinical trials for the stem cell based therapies. Major Players in the market focusing on R&D

Players are focusing on R&D to develop new treatment for diseases by using stem cells. For Instant, Center for stem cell biology and Regenerative Medicine is currently working with the University of Tokyo, to develop regenerative medicine by utilizing ERATO Nakauchi stem cells to treat organ failure.

Key players operating in the global stem cell Therapy market are Osiris, MEDIPOST, Anterogen, PHARMICELL Co., Ltd, Holostem Terapie Avanzate S.r.l.JCR Pharmaceuticals Co., NuVasive, Inc.,  RTI Surgical, Inc , and  AlloSource.

In addition, the study probes into the major factors such as import and export status, consumption volume, supply chain management, production capability and spending power to help business owners, stakeholders as well as field marketing executives zero in on profitable business strategies and stay competitive. A thorough analysis of intense competition among the top performers and strategies that have enabled them to occupy a strong foothold in the market makes the report a valuable resource for product owners exploring new avenues. All the vital information is presented through charts, graphs and tables and can be refereed for an industry specific presentation.

Submit a media release